Company
SpliceBio
Pioneering Protein Splicing: A Novel Gene Therapy Modality
Also known as Splice Bio
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Barcelona, Spain
- Founded
- 2014
- splice.bio (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
SpliceBio is a genetic medicines company harnessing its proprietary Protein Splicing platform to develop the next generation of gene therapies.
Funding snapshot
- Total raised
- $135MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series B, $135M2025-06-11
Funding rounds
- Series B
- $135M2025-06-11, Company stated
- Series A
- 2022-02-16
Products
- Other
- SB-007
- Web
- SB-007
Loading relationship preview